2025-06-24-艾昆纬-自信而专注地创新-通过利用新的工具和方法_提高设计_规划和试验交付的可预测性和质量（英）_10页_875kb

Summary of White Paper: Innovating with Confidence and Focus

Introduction

The white paper discusses how IQVIA's advanced tools, including AI and machine learning, enhance predictability and quality in clinical trial design, planning and delivery. It emphasizes that risk management is fundamental in clinical research, and sponsors can leverage innovation to reduce uncertainties.

Key Concepts

• The evolution of analytics: Moving from descriptive (summarizing past data) to predictive (forecasting future events) and prescriptive (suggesting specific actions to achieve desired outcomes).
• Foundation of confidence: Preparation and predictability are crucial for success in clinical trials, supported by better decision-making through data-driven insights.

Innovations Highlighted

• Clinical development planning: Using Healthcare-grade AI to assess asset viability, optimize protocols, and incorporate regulatory intelligence.
• Study design optimization: Protocol digitization reduces complexity and burden, enabling real-time adjustments and improved patient site experiences.
• Enrollment strategies: AI models for accurate enrollment forecasting and scenario generation, particularly in diverse regions.
• Regulatory intelligence: Leveraging historical data to streamline compliance and site startup, especially in emerging markets.
• Future role of agentic AI: This technology automates multi-step processes, improving speed, precision, and trust in clinical research workflow.

Looking Ahead and Conclusion

Agentic AI will drive efficiency in clinical trials, from trial design to commercialization. IQVIA aims to empower the pharmaceutical industry with cutting-edge tools to innovate confidently and reduce risks, ultimately accelerating the delivery of effective treatments. This white paper is part of a series on clinical research innovations.